Abstract
Anti-acetylcholine receptor (AChR) antibodies have been determined in the sera of ten myasthenic patients over a period of several months which in each case included a series of plasma-exchanges coupled with immunosuppressive therapy. The ratio of anti-(extra-junctional rat AChR): anti-(human AChR) antibody titres was found to vary with the patient but to be constant for a given patient over the period of study. Similar indications of a patient-specific anti-AChR antibody pattern were obtained by using junctional as well as extra-junctional rat AChR and also by precipitation of human AChR in the presence of excess antiserum. Individual anti-AChR antibody patterns may have relevance to the varying courses taken by myasthenia gravis in different patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Behan P. O., Shakir R. A., Simpson J. A., Burnett A. K., Allan T. L., Haase G. Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. Lancet. 1979 Sep 1;2(8140):438–440. doi: 10.1016/s0140-6736(79)91492-2. [DOI] [PubMed] [Google Scholar]
- Dau P. C., Lindstrom J. M., Cassel C. K., Denys E. H., Shev E. E., Spitler L. E. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med. 1977 Nov 24;297(21):1134–1140. doi: 10.1056/NEJM197711242972102. [DOI] [PubMed] [Google Scholar]
- Dau P. C., Yano C. S., Ettinger S. J. Antibody to acetylcholine receptor in canine and human myasthenia gravis: differential cross-reactivity with human and rabbit receptor. Neurology. 1979 Jul;29(7):1065–1068. doi: 10.1212/wnl.29.7.1065. [DOI] [PubMed] [Google Scholar]
- Lefvert A. K., Bergström K., Matell G., Osterman P. O., Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry. 1978 May;41(5):394–403. doi: 10.1136/jnnp.41.5.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976 Nov;26(11):1054–1059. doi: 10.1212/wnl.26.11.1054. [DOI] [PubMed] [Google Scholar]
- Lindstrom J. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol. 1977 Jan;7(1):36–43. doi: 10.1016/0090-1229(77)90027-7. [DOI] [PubMed] [Google Scholar]
- Marengo T. S., Harrison R., Lunt G. G., Behan P. O. Rat or human acetylcholine-receptor antigen for investigation of myasthenia gravis? Lancet. 1979 Feb 24;1(8113):442–442. doi: 10.1016/s0140-6736(79)90919-x. [DOI] [PubMed] [Google Scholar]
- Mittag T. W., Tormay A., Massa T. Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis. Mol Pharmacol. 1978 Jan;14(1):60–68. [PubMed] [Google Scholar]
- Simpson J. A. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2. Muscle Nerve. 1978 Mar-Apr;1(2):151–156. doi: 10.1002/mus.880010208. [DOI] [PubMed] [Google Scholar]
- Vincent A., Newsom-Davis J. alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor. Adv Cytopharmacol. 1979;3:269–278. [PubMed] [Google Scholar]
- Weinberg C. B., Hall Z. W. Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors. Proc Natl Acad Sci U S A. 1979 Jan;76(1):504–508. doi: 10.1073/pnas.76.1.504. [DOI] [PMC free article] [PubMed] [Google Scholar]